Joanna Pepke-Zaba

TL;DR: Although SVR fell substantially after prostacyclin in patients with pulmonary hypertension, inhaled NO had no effect on SVR in any patient or volunteer, and seems to be both a selective and effective pulmonary vasodilator.

TL;DR: Despite similarities in clinical presentation, operable and nonoperable CTEPH patients may have distinct associated medical conditions.

TL;DR: Dysregulation of a broad range of inflammatory mediators in idiopathic and familial PAH demonstrates that cytokine levels have a previously unrecognized impact on patient survival and cytokines may prove to be useful biomarkers and provide insight into the contribution of inflammation in PAH.

TL;DR: Survival of patients with SSc-PAH in the modern treatment era is better than in historical series, and a significant proportion of patientswith mild functional impairment or exercise-induced pulmonary arterial hypertension have evidence of disease progression.

TL;DR: Pulmonary endarterectomy is associated with a low in-hospital mortality rate and improvements in hemodynamics and exercise capacity and New York Heart Association functional class improved.